NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

meirluc, NFL football fans may know that when a new rule is implemented for a new season, very often during the preseason, that rule is the focus of the referees attention and they will call the penalty excessively in order to get the attention of the teams about the new rule.

Similarly, some regulators/inspectors will do the same, and focus their attention on certain elements during an inspection, (like computerized systems) and a new system like Flaskworks, will receive extra scrutiny. This potential additional validation was pure speculation on my part. I’m very familiar with a small company like Advent, with limited resources and experience, and I think it’s possible that Advent anticipated that the inspectors would find some issues that were insufficient, and allowed the inspectors to pinpoint exactly what they were looking for, and then Advent addressed the specific issues. If there was going to be an excessive delay, I think Northwest Bio would inform shareholders. So far this hasn’t occurred, so I’m optimistic for an update by the end of the year as well.